Results 191 to 200 of about 1,133,085 (338)

From Science to Innovation in Aquatic Animal Nutrition: A Global TRL-Based Assessment of Insect-Derived Feed Technologies via Scientific Publications and Patents. [PDF]

Animals (Basel)
Quintella CM, Ghesti GF, Salgado R, Mata AMAT.   +3 more
europepmc   +1 more source

The Effect of Patent Citation Relationship on Business Performance : A Social Network Analysis Perspective

, 2013
Junhyung Park, Kee-Young Kwahk
openalex   +2 more sources

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

Recent changes in discretionary denials of drug patent challenges. [PDF]

Health Aff Sch
Tu SS, Rai A, Kesselheim AS.
europepmc   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

Contrastive learning enhanced retrieval-augmented few-shot framework for multi-label patent classification. [PDF]

PLoS One
Zheng W, Li X, Cui G, Chen S.
europepmc   +1 more source

Current controversies in the management of patent ductus arteriosus in preterm infants [PDF]

, 2014
Thowfique Ibrahim, Abdul Alim Abdul Haium, Suresh Chandran, Victor Samuel Rajadurai   +3 more
openalex   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Patent quality and trade credit: Based on the perspective of knowledge breadth. [PDF]

PLoS One
Li Y, Wang M.
europepmc   +1 more source

Mixed R&D Incentives: The Effect of R&D Subsidies on Patented Inventions

, 2008
Cédric Schneider
openalex   +1 more source